Schedule 13G ownership disclosure
PHIO PHARMACEUTICALS CORP
Common Stock, par value $0.0001 per share · CUSIP: 71880W501
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 90,988 · Class: 4.9%
- Heights Capital Management, Inc.
Shares: 90,988 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-25-000039
- Form type
- SCHEDULE 13G/A
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- Feb 07, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership